Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gougeon
Alain Gougeon, Chaponost FR
| Patent application number | Description | Published |
|---|---|---|
| 20100152102 | USE OF SOMATOSTATIN OR ONE OF ITS ANALOGUES FOR PREPARING A MEDICAMENT INTENDED TO REGULATE THE OVARIAN FOLLICULAR RESERVE IN NON-MENOPAUSAL WOMEN - The invention primarily relates to the use of somatostatin or one of the agonistic analogs thereof for producing a medicament serving to regulate the ovarian follicular reserve and, in particular, to reduce the depletion of the ovarian follicular reserve over time in non-menopausal women or to the use of an antagonistic analog of somatostatin for producing a medicament serving to accelerate the start of growing of quiescent follicles in non-menopausal women. The invention also relates to in vitro applications of somatostatin and of agonistic and antagonistic analogs thereof. | 06-17-2010 |
| 20110003749 | USE OF SOMATOSTATIN OR ONE OF ITS ANALOGUES FOR PREPARING A MEDICAMENT INTENDED TO REGULATE THE OVARIAN FOLLICULAR RESERVE IN NON-MENOPAUSAL WOMEN - The invention primarily relates to the use of somatostatin or one of the agonistic analogs thereof for producing a medicament serving to regulate the ovarian follicular reserve and, in particular, to reduce the depletion of the ovarian follicular reserve over time in non-menopausal women or to the use of an antagonistic analog of somatostatin for producing a medicament serving to accelerate the start of growing of quiescent follicles in non-menopausal women. The invention also relates to in vitro applications of somatostatin and of agonistic and antagonistic analogs thereof. | 01-06-2011 |
Marie-Lise Gougeon, Clamart FR
| Patent application number | Description | Published |
|---|---|---|
| 20100158912 | MONITORING AND INHIBITING HUMAN IMMUNODEFICIENCY VIRUS INFECTION BY MODULATING HMGB1 DEPENDENT TRIGGERING OF HIV-1 REPLICATION AND PERSISTENCE - Compositions and methods for modulating human immunodeficiency virus (HIV) infection involving substances that inhibit the ability of high mobility box 1 (HMGB1) protein to interact with natural killer (NK) cells. Therapeutic compositions comprising antibodies and drugs, such as glycyrrhizin, which bind to HMGB1. Methods of detecting or monitoring HIV infection involving detection or quantitation of HMGB1 or antibodies specific for HMGB1 in a biological sample. | 06-24-2010 |
Pierre Gougeon, Rosemere CA
| Patent application number | Description | Published |
|---|---|---|
| 20080232584 | HAND-HELD DECODER CARD HAVING A PARALLAX BARRIER PORTION AND A LIGHT FILTERING PORTION AND METHOD OF MAKING SAME - The present document describes a hand-held decoder card for revealing information hidden in a printed material and information hidden in a color image and method of making the same. The hand-held decoder card comprises: translucent material having a parallax barrier portion comprising parallel barrier lines for revealing the information hidden in the printed material; and the translucent material having a light filtering portion comprising a light filter for revealing the information hidden in the color image. According to various embodiments, the hand-held decoder card is in a transactional card format. The card may include only the parallax barrier portion or the light filtering portion. Also, the hand-held card may be a monocoque card or a laminated card. | 09-25-2008 |
Sebastien Gougeon, Porcelette FR
| Patent application number | Description | Published |
|---|---|---|
| 20090271892 | LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE GENES AND USES THEREOF - The present invention relates to the identification and characterization of new lysophosphatidic acid acyltransferases (LPAAT) as well as to the use of these enzymes for modifying plants for efficient production of modified lipids. | 10-29-2009 |